ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ABBV AbbVie Inc

163.79
2.98 (1.85%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
AbbVie Inc NYSE:ABBV NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  2.98 1.85% 163.79 164.25 160.74 161.85 5,850,104 01:00:00

Specialized Disclosure Report (sd)

31/05/2019 10:01pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

 


 

FORM SD

 

SPECIALIZED DISCLOSURE REPORT

 

AbbVie Inc.

(Exact name of registrant as specified in its charter)

 


 

Delaware

 

001-35565

 

32-0375147

(State or other Jurisdiction

 

(Commission File Number)

 

(IRS Employer

of Incorporation)

 

 

 

Identification No.)

 


 

1 North Waukegan Road

North Chicago, Illinois 60064-6400

(Address of principal executive offices)(Zip Code)

 

Robert A. Michael (847) 932-7900

(Name and telephone number, including area code, of the person to contact in connection with this report.)

 

Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:

 

x Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2018.

 

 

 


 

SECTION 1 — CONFLICT MINERALS DISCLOSURE

 

Item 1.01.                           Conflict Minerals Disclosure and Report

 

The Conflict Minerals Report for AbbVie Inc. (AbbVie) for the year ended December 31, 2018 is attached as Exhibit 1.01 to this Report and is available on AbbVie’s website at www.abbvieinvestor.com .

 

Item 1.02.                           Exhibit

 

AbbVie’s Conflict Minerals Report is attached as Exhibit 1.01 to this Report.

 

SECTION 2 — EXHIBITS

 

Item 2.01.                            Exhibits

 

Exhibit No.

 

Description

Exhibit 1.01

 

Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.

 

 

AbbVie Inc.

 

 

(Registrant)

 

 

 

 

 

 

 

 

 

By:

/s/ Robert A. Michael

 

Date:  May 31, 2019

 

Robert A. Michael

 

 

 

Senior Vice President, Chief Financial Officer

 

 

 

3


 

EXHIBIT INDEX

 

Exhibit No.

 

Description

Exhibit 1.01

 

Conflict Minerals Report.

 

4


1 Year AbbVie Chart

1 Year AbbVie Chart

1 Month AbbVie Chart

1 Month AbbVie Chart

Your Recent History

Delayed Upgrade Clock